Approximately 50% of participants achieved at least 20% weight reduction, representing weight loss magnitudes that overlap with those seen in some bariatric surgery studies, though long-term durability and effects on comorbidities may differ
Currently valued at $3 billion, this market is projected to reach $5 billion
The other physiological effects of GLP-1 are slow gastric emptying, low appetite and reduced energy/food intake promoting weight loss/control
The peptide in solution is far more susceptible to degradation than lyophilized powder
In its reduced state, glutathione is "ready for work." It has an extra electron that it can give away to neutralize a free radical
Hypoglycemia & Semaglutide While the risk of hypoglycemia (low blood sugar) is relatively low when semaglutide is used for weight management, it is still possible, especially if combined with other diabetes medications or insulin